Latest news
NHS England approves delayed-release treatment for rare kidney disease - PharmafilePharmafile · Mon, 10 Aug 2026 12:42:44 GMTMironid raises £34m to advance treatment for rare kidney disease - UKTNUKTN · Mon, 10 Aug 2026 08:00:53 GMTGlasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-StartupsEU-Startups · Fri, 07 Aug 2026 12:14:34 GMTVERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics - StocktwitsStocktwits · Fri, 07 Aug 2026 09:09:07 GMTMironid - Via RitzauVia Ritzau · Wed, 05 Aug 2026 06:00:00 GMT